Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.71 AUD | -1.90% | +0.90% | +3.39% |
Summary
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- The opinion of analysts covering the stock has improved over the past four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- One of the major weak points of the company is its financial situation.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- For the past year, analysts have significantly revised downwards their profit estimates.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+3.39% | 3B | B+ | ||
+3.05% | 95.15B | B | ||
+1.78% | 94.71B | B- | ||
-20.65% | 77.24B | B+ | ||
+18.68% | 74.93B | D+ | ||
+6.69% | 30.04B | B | ||
+18.06% | 27.87B | B | ||
+4.32% | 26.97B | A | ||
-1.21% | 16.99B | C+ | ||
-9.10% | 15.16B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- CGF Stock
- Ratings Challenger Limited